Jason Wittes, PharmD, has been elected to serve on the Hemophilia Alliance Board of Directors beginning in October 2024.
The Hemophilia Alliance is a not-for-profit organization that comprises federally funded hemophilia treatment centers (HTCs) that either have, or are seeking to have, pharmacy programs under Section 340B of the Public Health Service Act. The Alliance ensures HTCs have the expertise, resources and public support to sustain their integrated clinical and pharmacy services for individuals with bleeding and clotting disorders.
“I joined the board to provide insights to the Hemophilia Alliance regarding medication purchasing, medication access, and payer relations,” Dr. Wittes said. “Through this opportunity, I hope to further advocate for patients with bleeding disorders and continue to champion medication access for patients in North Carolina and throughout the country.”
Dr. Wittes is Director of Pharmacy Programsfor the UNC Hemophilia Treatment Center Pharmacy and the Ryan White/Infectious Disease pharmacy programs. In addition to these roles, Dr. Wittes currently serves on the NC DHHS Medicaid Drug Utilization Review Board and previously served as a member of the MMCAP Infuse National Advisory Board and Apexus Title X 340B Advisory Board. Dr. Wittes is also a Robert Wood Johnson Foundation Clinical Scholar Fellow, a program focusing on clinical leadership and advancing health equity.